NM_001361665.2:c.*1349G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001361665.2(FGF2):c.*1349G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.413 in 152,096 control chromosomes in the GnomAD database, including 15,851 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.41 ( 15846 hom., cov: 33)
Exomes 𝑓: 0.44 ( 5 hom. )
Consequence
FGF2
NM_001361665.2 3_prime_UTR
NM_001361665.2 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.190
Publications
19 publications found
Genes affected
FGF2 (HGNC:3676): (fibroblast growth factor 2) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members bind heparin and possess broad mitogenic and angiogenic activities. This protein has been implicated in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. The mRNA for this gene contains multiple polyadenylation sites, and is alternatively translated from non-AUG (CUG) and AUG initiation codons, resulting in five different isoforms with distinct properties. The CUG-initiated isoforms are localized in the nucleus and are responsible for the intracrine effect, whereas, the AUG-initiated form is mostly cytosolic and is responsible for the paracrine and autocrine effects of this FGF. [provided by RefSeq, Jul 2008]
NUDT6 (HGNC:8053): (nudix hydrolase 6) This gene overlaps and lies on the opposite strand from FGF2 gene, and is thought to be the FGF2 antisense gene. The two genes are independently transcribed, and their expression shows an inverse relationship, suggesting that this antisense transcript may regulate FGF2 expression. This gene has also been shown to have hormone-regulatory and antiproliferative actions in the pituitary that are independent of FGF2 expression. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.552 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FGF2 | NM_001361665.2 | c.*1349G>A | 3_prime_UTR_variant | Exon 3 of 3 | ENST00000644866.2 | NP_001348594.1 | ||
| NUDT6 | NM_007083.5 | c.554-520C>T | intron_variant | Intron 4 of 4 | ENST00000304430.10 | NP_009014.2 | ||
| FGF2 | NM_002006.6 | c.*1349G>A | 3_prime_UTR_variant | Exon 3 of 3 | NP_001997.5 | |||
| NUDT6 | NM_198041.3 | c.47-520C>T | intron_variant | Intron 4 of 4 | NP_932158.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.413 AC: 62737AN: 151942Hom.: 15840 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
62737
AN:
151942
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.444 AC: 16AN: 36Hom.: 5 Cov.: 0 AF XY: 0.563 AC XY: 9AN XY: 16 show subpopulations
GnomAD4 exome
AF:
AC:
16
AN:
36
Hom.:
Cov.:
0
AF XY:
AC XY:
9
AN XY:
16
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
AC:
0
AN:
2
South Asian (SAS)
AF:
AC:
1
AN:
2
European-Finnish (FIN)
AF:
AC:
3
AN:
4
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
11
AN:
26
Other (OTH)
AF:
AC:
1
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.413 AC: 62747AN: 152060Hom.: 15846 Cov.: 33 AF XY: 0.410 AC XY: 30484AN XY: 74308 show subpopulations
GnomAD4 genome
AF:
AC:
62747
AN:
152060
Hom.:
Cov.:
33
AF XY:
AC XY:
30484
AN XY:
74308
show subpopulations
African (AFR)
AF:
AC:
4612
AN:
41508
American (AMR)
AF:
AC:
7335
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
1583
AN:
3468
East Asian (EAS)
AF:
AC:
2337
AN:
5174
South Asian (SAS)
AF:
AC:
1211
AN:
4822
European-Finnish (FIN)
AF:
AC:
6275
AN:
10538
Middle Eastern (MID)
AF:
AC:
86
AN:
292
European-Non Finnish (NFE)
AF:
AC:
37822
AN:
67960
Other (OTH)
AF:
AC:
931
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1623
3246
4869
6492
8115
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
556
1112
1668
2224
2780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1246
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.